CARBOCAIN Side Effects

6960314-8 | Anaphylactic Shock
on Aug 24, 2010 Male patient from JAPAN , 28 years of age, weighting 143.3 lb, was diagnosed with epidural anaesthesia, infection prophylaxis, anaesthesia procedure and was treated with Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Carbocain dosage: . During the same period patient was treated with CEFAMEZIN ALPHA (View Cefamezin Alpha Review and Cefamezin Alpha Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), SOLACET F (View Solacet F Review and Solacet F Label ), PHYSIO 140 (View Physio 140 Review and Physio 140 Label ). Patient was hospitalized.

6918759-8 | Anaphylactic Shock
Patient was taking Carbocain (View Usage). Patient had the following side effects: anaphylactic shock on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with epidural anaesthesia, infection prophylaxis, anaesthesia procedure and. Carbocain dosage: . During the same period patient was treated with CEFAMEZIN ALPHA (View Cefamezin Alpha Review and Cefamezin Alpha Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), 1% DIPRIVAN (View 1% Diprivan Review and 1% Diprivan Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), SOLACET F (View Solacet F Review and Solacet F Label ), PHYSIO 140 (View Physio 140 Review and Physio 140 Label ). Patient was hospitalized.

6663952-5 |
Adverse event was reported on Mar 29, 2010 by a Male patient taking Carbocain (View Usage) (Dosage: 10cc X 5 Ampules, At 3ml/hour) . Location: JAPAN , weighting 145.5 lb, . During the same period patient was treated with SEISHOKU (100 Ml Every Day, Carbocaine Was Mixed With Saline Solution And Administered) (View Seishoku Review and Seishoku Label ).

6620940-2 | Dyskinesia, Erythema, Lip Swelling, Swollen Tongue
on Mar 08, 2010 Female patient from UNITED STATES , 62 years of age, weighting 115.0 lb, was diagnosed with endodontic procedure and was treated with Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, erythema, lip swelling, swollen tongue. Carbocain dosage: . During the same period patient was treated with SEPTOCAINE (View Septocaine Review and Septocaine Label ).


6430111-0 | Cerebral Infarction, Disseminated Intravascular Coagulation, Renal Failure, Shock, Toxic Epidermal Necrolysis
on Oct 28, 2009 Female patient from JAPAN , 87 years of age, was diagnosed with local anaesthesia and was treated with Carbocain (View Usage). Patient had the following side effects: cerebral infarction, disseminated intravascular coagulation, renal failure, shock, toxic epidermal necrolysis. Carbocain dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), CEFCAPENE PIVOXIL HYDROCHLORIDE (View Cefcapene Pivoxil Hydrochloride Review and Cefcapene Pivoxil Hydrochloride Label ), INTRAARTICULAR STEROID INJECTION (View Intraarticular Steroid Injection Review and Intraarticular Steroid Injection Label ). Patient was hospitalized.

6301373-5 | Anaphylactic Shock
Patient was taking Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: anaphylactic shock on Jul 31, 2009 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with nerve block and. Carbocain dosage: .

6146006-6 | Movement Disorder, Sensory Disturbance
Adverse event was reported on Mar 31, 2009 by a Male patient taking Carbocain (View Usage) (Dosage: 2 Ml X1, 4 Ml X5) was diagnosed with epidural anaesthesia, blood pressure decreased, maintenance of anaesthesia, cholinergic syndrome and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: movement disorder (What is movement disorder?), sensory disturbance. During the same period patient was treated with ANAPEINE (0.2% 188 Ml (4 Ml/hr). Patient Controlled Amount: 3 Ml.) (View Anapeine Review and Anapeine Label ), EPHEDRIN (View Ephedrin Review and Ephedrin Label ), SEVOFLURANE (0.8-1.5 %) (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (3-4 L/min) (View Nitrous Oxide Review and Nitrous Oxide Label ), VECURONIUM BROMIDE (7 Mg X1, 1 Mg X4) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), ATROPINE (View Atropine Review and Atropine Label ).

6100205-8 | Movement Disorder, Sensory Disturbance
on Feb 24, 2009 Male patient from JAPAN , 66 years of age, was diagnosed with epidural anaesthesia, blood pressure decreased, maintenance of anaesthesia, cholinergic syndrome and was treated with Carbocain (View Usage). Patient had the following side effects: movement disorder (What is movement disorder?), sensory disturbance. Carbocain dosage: 2 Ml X1, 4 Ml X5. During the same period patient was treated with NAROPIN (0.2% 188 Ml (4 Ml/hr). Patient Controlled Amount: 3 Ml.) (View Naropin Review and Naropin Label ), EPHEDRIN (View Ephedrin Review and Ephedrin Label ), SEVOFLURANE (0.8-1.5 %) (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (3-4 L/min) (View Nitrous Oxide Review and Nitrous Oxide Label ), VECURONIUM BROMIDE (7 Mg X1, 1 Mg X4) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), ATROPINE (View Atropine Review and Atropine Label ).

6091262-6 | Chest Discomfort, Dizziness, Dyspnoea, Fatigue, Nausea, Paraesthesia, Presyncope, Tremor
on Feb 20, 2009 Female patient from UNITED STATES , 33 years of age, weighting 110.0 lb, was diagnosed with dental care and was treated with Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: chest discomfort, dizziness (What is dizziness?), dyspnoea, fatigue, nausea (What is nausea?), paraesthesia, presyncope, tremor. Carbocain dosage: . Patient was hospitalized.

6023426-1 | Hypoaesthesia, Muscular Weakness
Patient was taking Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, muscular weakness on Dec 24, 2008 from JAPAN Additional patient health information: Female patient , 49 years of age, weighting 125.7 lb, was diagnosed with epidural anaesthesia, analgesia and. Carbocain dosage: . During the same period patient was treated with NAROPIN (View Naropin Review and Naropin Label ), FENTANYL 100 (Mixed With 3 Micg/ml Of 0.2% Ropivacaine And Administered Continuously At 4 Ml/h.) (View Fentanyl-100 Review and Fentanyl-100 Label ).

5956955-7 | Movement Disorder
Adverse event was reported on Nov 13, 2008 by a Female patient taking Carbocain (View Usage) (Dosage: 1% 7 Cc) was diagnosed with epidural anaesthesia and. Location: JAPAN , 58 years of age, Patient had the following side effects: movement disorder (What is movement disorder?). During the same period patient was treated with CELESTONE (1 Cc) (View Celestone Review and Celestone Label ), ISOTONIC SODIUM CHLORIDE SOLUTION (7 Cc) (View Isotonic Sodium Chloride Solution Review and Isotonic Sodium Chloride Solution Label ).

5385478-1 | Extradural Haematoma, Pulmonary Embolism
on Jun 28, 2007 Male patient from JAPAN , 65 years of age, was diagnosed with epidural anaesthesia, induction of anaesthesia, maintenance of anaesthesia and was treated with Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: extradural haematoma, pulmonary embolism (What is pulmonary embolism?). Carbocain dosage: . During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MORPHINE (View Morphine Review and Morphine Label ).

5217501-9 | Oxygen Saturation Decreased
on Jan 18, 2007 Female patient from JAPAN , 62 years of age, was diagnosed with anaesthesia and was treated with Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: oxygen saturation decreased. Carbocain dosage: .

5151283-4 | Extradural Haematoma, Post Procedural Complication
Patient was taking Carbocain (View Usage). Patient had the following side effects: extradural haematoma, post procedural complication on Oct 25, 2006 from JAPAN Additional patient health information: Male patient , 88 years of age, was diagnosed with epidural anaesthesia, analgesic effect and. Carbocain dosage: . During the same period patient was treated with ANAPEINE (View Anapeine Review and Anapeine Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ). Patient was hospitalized.

5148997-9 | Oxygen Saturation Decreased
Adverse event was reported on Nov 02, 2006 by a Female patient taking Carbocain (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: JAPAN , 62 years of age, After Carbocain was administered, patient had the following side effects: oxygen saturation decreased.

5144915-8 | Anaesthetic Complication, Extradural Haematoma
on Oct 25, 2006 Male patient from JAPAN , 88 years of age, was diagnosed with epidural anaesthesia, analgesic effect and was treated with Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication, extradural haematoma. Carbocain dosage: . During the same period patient was treated with ANAPEINE (View Anapeine Review and Anapeine Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ). Patient was hospitalized.

4930454-3 | Cough, Extradural Haematoma, Feeling Cold, Pain In Extremity
on Feb 08, 2006 Female patient from JAPAN , 76 years of age, weighting 132.3 lb, was diagnosed with epidural anaesthesia and was treated with Carbocain (View Usage). Patient had the following side effects: cough, extradural haematoma, feeling cold, pain in extremity. Carbocain dosage: . During the same period patient was treated with NORMAL SALINE (View Normal Saline Review and Normal Saline Label ). Patient was hospitalized.

4912011-8 | Extradural Haematoma, Iatrogenic Injury, Spinal Cord Injury
Patient was taking Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: extradural haematoma, iatrogenic injury, spinal cord injury on Feb 08, 2006 from JAPAN Additional patient health information: Female patient , 76 years of age, weighting 132.3 lb, was diagnosed with epidural anaesthesia and. Carbocain dosage: . During the same period patient was treated with NORMAL SALINE (View Normal Saline Review and Normal Saline Label ). Patient was hospitalized.

4815749-6 | Conversion Disorder
Adverse event was reported on Oct 19, 2005 by a Female patient taking Carbocain (View Usage) (Dosage: ) was diagnosed with nerve block and. Location: JAPAN , 45 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: conversion disorder. Patient was hospitalized.

4708359-2 | Asthma, Cyanosis
on Jun 01, 2005 Female patient from JAPAN , weighting 183.0 lb, was diagnosed with infiltration anaesthesia and was treated with Carbocain (View Usage). Patient had the following side effects: asthma (What is asthma?), cyanosis. Carbocain dosage: . During the same period patient was treated with MEILAX (View Meilax Review and Meilax Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), TERNELIN (View Ternelin Review and Ternelin Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), SELBEX (View Selbex Review and Selbex Label ).

4703190-6 | Hypotension
on Jun 01, 2005 Male patient from , 70 years of age, was diagnosed with epidural anaesthesia, induction of anaesthesia, bipolar i disorder, hypotonia, maintenance of anaesthesia and was treated with Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: hypotension. Carbocain dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), XYLOCAINE W/ EPINEPHRINE (View Xylocaine W/ Epinephrine Review and Xylocaine W/ Epinephrine Label ), MUSCULAX (View Musculax Review and Musculax Label ), LAUGHING GAS (View Laughing Gas Review and Laughing Gas Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MORPHINE (View Morphine Review and Morphine Label ).

4701578-0 | Spinal Cord Infarction
Patient was taking Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: spinal cord infarction on Jun 01, 2005 from Additional patient health information: Male patient , 75 years of age, was diagnosed with epidural anaesthesia, induction of anaesthesia and. Carbocain dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), ANAPEINE (View Anapeine Review and Anapeine Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

4701572-X | Blood Pressure Decreased
Adverse event was reported on Jun 01, 2005 by a Male patient taking Carbocain (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, induction of anaesthesia, bipolar i disorder, hypotonia, maintenance of anaesthesia and. Location: , 70 years of age, Patient had the following side effects: blood pressure decreased. During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), XYLOCAINE W/ EPINEPHRINE (View Xylocaine W/ Epinephrine Review and Xylocaine W/ Epinephrine Label ), MUSCULAX (View Musculax Review and Musculax Label ), LAUGHING GAS (View Laughing Gas Review and Laughing Gas Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MORPHINE (View Morphine Review and Morphine Label ).

4701121-6 | Asthma, Cyanosis, Myofascial Pain Syndrome
on Jun 17, 2005 Female patient from , 29 years of age, was diagnosed with infiltration anaesthesia and was treated with Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: asthma (What is asthma?), cyanosis, myofascial pain syndrome. Carbocain dosage: 3 Ml Daily. During the same period patient was treated with MEILAX (View Meilax Review and Meilax Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), TERNELIN (View Ternelin Review and Ternelin Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), SELBEX (View Selbex Review and Selbex Label ).

4696214-6 | Asthma, Face Oedema
on Jun 01, 2005 Female patient from , 36 years of age, was treated with Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), face oedema. Carbocain dosage: .

4690446-9 | Delayed Recovery From Anaesthesia, Spinal Cord Infarction
Patient was taking Carbocain (View Usage). Patient had the following side effects: delayed recovery from anaesthesia, spinal cord infarction on Jun 01, 2005 from Additional patient health information: Male patient , 75 years of age, was diagnosed with epidural anaesthesia and. Carbocain dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), ANAPEINE (View Anapeine Review and Anapeine Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

4689116-2 | Asthma, Oedema, Type Iv Hypersensitivity Reaction
Adverse event was reported on Jun 01, 2005 by a Female patient taking Carbocain (View Usage) (Dosage: ) . Location: , 36 years of age, After Carbocain was administered, patient had the following side effects: asthma (What is asthma?), oedema, type iv hypersensitivity reaction.

4689115-0 | Asthma, Condition Aggravated, Cyanosis
on Jun 01, 2005 Female patient from , 29 years of age, was diagnosed with infiltration anaesthesia and was treated with Carbocain (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), condition aggravated, cyanosis. Carbocain dosage: .

4688026-4 | Blood Pressure Decreased
on Jun 01, 2005 Male patient from , 70 years of age, was diagnosed with epidural anaesthesia, induction of anaesthesia, bipolar i disorder and was treated with Carbocain (View Usage). Patient had the following side effects: blood pressure decreased. Carbocain dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), MILNACIPRAN (View Milnacipran Review and Milnacipran Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

4596057-8 | Anaesthetic Complication, Arteriospasm Coronary, Blood Pressure Increased, Electrocardiogram St Segment Elevation, Haemodynamic Instability, Nerve Block, Procedural Complication, Procedural Hypotension
Patient was taking Carbocain (View Usage). After Carbocain was administered, patient had the following side effects: anaesthetic complication, arteriospasm coronary, blood pressure increased, electrocardiogram st segment elevation, haemodynamic instability, nerve block, procedural complication, procedural hypotension on Feb 09, 2005 from Additional patient health information: Male patient , 37 years of age, was diagnosed with epidural anaesthesia, blood pressure decreased and. Carbocain dosage: 4 Ml/hr Ed. During the same period patient was treated with EPHEDRINE HYDROCHLORIDE (8 Mg Daily) (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ), PRAZOSIN HYDROCHLORIDE (View Prazosin Hydrochloride Review and Prazosin Hydrochloride Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ).

4564130-6 | Catheter Site Erythema, Catheter Site Infection, Extradural Abscess, Gastric Ulcer Haemorrhage, Haemoglobin Decreased, Headache, Helicobacter Infection, Muscular Weakness, Purulence
Adverse event was reported on Jan 13, 2005 by a Male patient taking Carbocain (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia and. Location: , 80 years of age, Patient experienced the following unwanted or unexpected effects: catheter site erythema, catheter site infection, extradural abscess, gastric ulcer haemorrhage, haemoglobin decreased, headache (What is headache?), helicobacter infection, muscular weakness, purulence.